2-(5-Fluoro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

3-Methyl-1-(2-methylprop-1-en-1-yl)-1H-1,2,3-benzotriazol-3-ium iodide, 95.0%, 25mg

1-(3-Hydroxypropyl)pyrrolidin-2-one, 97.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 97%, 25g

7-bromo-3H,4H-pyrido[3,2-d]pyrimidin-4-one, 500mg

(E)-3-(4-Fluoro-phenyl)-acryloyl chloride, 95.0%, 10g

Pritelivir, 99.03%, 5mg

2,3,5-Trichloropyrazine, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-5, 25 m, 0.25 mm, 0.10 µm, 1 Pezzo(i)

N1,N1-Dimethylbenzene-1,3-diamine dihydrochloride, 95.0%, 5g

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

5-Bromo-6-nitro-1H-indazole, 95.0%, 5g

2,5-Difluorophenylacetylene, 97.0%, 2.5g